PATENT CLAIM ANALYSIS

Application Number: 16308690
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["546", "277700"]

Abstract:
The present invention concern a 2-oxo-1,2-dihydropyridine-3-carboxamide compound of Formula (I) in the treatment of pathologies which require a dual inhibitor of PDK1/AurA enzymes such as for instance tumours, particularly glioblastoma.

Claim (Index 18):
The compound of  claim 17 , wherein the compound is (Z)\u2014N-(2-((3-((1H-imidazol-5-yl)methylene)-2-oxoindolin-5-yl)amino)-2-oxoethyl)-1-(3,4-difluorobenzyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide (SST200) or (R,Z)\u2014N-(2-((3-((1H-imidazol-5-yl)methylene)-2-oxoindolin-5-yl)amino)-2-oxo-1-phenylethyl)-1-(3,4-difluorobenzyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide (VI8).

Metadata:
- Claim Count in Document: 65.0
- Percentile: 98.0
- Lexical Diversity: 1.09677
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15735468', '13855916', '13699547', '13148903', '13651312']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8037202192799937
- 35 USC 102 Novelty (BERT): 0.6528584322018325
- Combined Prediction Score: 0.7886340405721777
- Mean Citation Score: 396.819224
- Max Citation Score: 671.692
- Similarity Product: 598.0572962393761

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test